Expert consensus on diagnosis and management of mucormycosis in China.
10.3760/cma.j.cn112138-20220729-00557
- Collective Name:Medical Mycology Society of Chinese Medicine and Education Association;Chinese Mucormycosis Expert Consensus Group
- Publication Type:Journal Article
- MeSH:
Humans;
Mucormycosis/drug therapy*;
Consensus;
China
- From:
Chinese Journal of Internal Medicine
2023;62(6):597-605
- CountryChina
- Language:Chinese
-
Abstract:
Mucormycosis is an important invasive fungal disease that is difficult to diagnose and treat, and has a high mortality rate. To improve the diagnosis and treatment of mucormycosis by clinicians, the Medical Mycology Society of Chinese Medicine and Education Association engaged multidisciplinary experts to compile this expert consensus. This consensus refers to the latest international guidelines for diagnosis and treatment of mucormycosis, combined with the characteristics and treatment needs of mucormycosis in China and covers the following eight aspects to provide reference for Chinese clinicians: pathogenic agents, high-risk factors, clinical types, imaging manifestations, etiological diagnosis, clinical diagnosis, treatment, and prevention.
